Evidence map›Paper›PMID 29890688›Full record

ArticleMolecules (Basel, Switzerland)2018

Hydrogen-Bonded Organic⁻Inorganic Hybrid Based on Hexachloroplatinate and Nitrogen Heterocyclic Cations: Their Synthesis, Characterization, Crystal Structures, and Antitumor Activities In Vitro.

Jin Zhao, Fuming Chen, Yutong Han, Huaqing Chen, Zhidong Luo, Hao Tian, Yi Zhao, Aiqing Ma, Longguan Zhu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jin ZhaoSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. vincent-vg@163.com.
Fuming ChenSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. fm.chen@siat.ac.cn.
Yutong HanSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. hyt7570@163.com.
Huaqing ChenGuangdong Key Laboratory of Nanomedicine, CAS Key Lab for Health Informatics, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulation, Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen 518055, China. chenhuaqing99@163.com.
Zhidong LuoSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. luozhidong06@126.com.
Hao TianSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. tianhao5588@126.com.
Yi ZhaoSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. zhaoyicomnet@gdmu.edu.cn.
Aiqing MaSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China. maqandght@126.com.
Longguan ZhuDepartment of Chemistry, Zhejiang University, Hangzhou 310027, China. chezlg@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three new crystal structures containing [PtCl₆]

Indexed as

Antineoplastic AgentsCationsCisplatinCrystallography, X-RayHeterocyclic CompoundsHydrogen BondingInorganic ChemicalsMolecular StructureNitrogenOrganic ChemicalsSpectrophotometry, UltravioletThermogravimetryAntineoplastic AgentsCationsCisplatindisodium hexachloroplatinateHeterocyclic CompoundsInorganic ChemicalsNitrogenOrganic Chemicalsantitumor activitieshydrogen bondingorganic–inorganic hybrid complexesstructure

Identifiers

PMID29890688
PMCPMC6099602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.